Histopathologic findings associated with APOL1 risk variants in chronic kidney disease

被引:48
|
作者
Larsen, Christopher P. [1 ]
Beggs, Marjorie L. [1 ]
Saeed, Mohammad [1 ]
Ambruzs, Josephine M. [1 ]
Cossey, L. Nicholas [1 ]
Messias, Nidia C. [1 ]
Walker, Patrick D. [1 ]
Freedman, Barry I. [2 ]
机构
[1] Nephropath, Little Rock, AR 72211 USA
[2] Wake Forest Sch Med, Winston Salem, NC USA
关键词
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; STAGE RENAL-DISEASE; AFRICAN-AMERICANS; HYPERTENSIVE NEPHROSCLEROSIS; CLASSIFICATION; MORPHOLOGY; HIV;
D O I
10.1038/modpathol.2014.92
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The effects of nephropathy risk variants in the apolipoprotein L1 gene (APOL1) on renal histopathology in African Americans with arterionephrosclerosis or putative 'hypertension-associated' nephropathy are unknown. APOL1 genotype-phenotype correlations were performed in a blinded manner from renal biopsies in 196 self-reported African Americans with arterionephrosclerosis on kidney biopsy at a large national nephropathology practice. Subjects had chronic kidney disease without nephrotic syndrome. A discovery analysis compared histopathologic changes in the glomerular and tubulointerstitial compartments in 58 subjects with 2 versus 56 subjects with 0 APOL1 risk variants. Validation was performed in biopsies from 82 additional subjects with 0, 1, and 2 risk variants. Two risk variant versus zero risk variant group genotype associations and subphenotypes were assessed by chi(2) analyses. ANOVA compared means of continuous variables. In discovery analyses, significantly less obsolescent glomerulosclerosis, more (solidified and disappearing) glomerulosclerosis, more thyroidization-type tubular atrophy, and more microcystic tubular dilatation were seen in patients with two versus zero APOL1 risk alleles. Greater degrees of arteriosclerosis were present in those with zero risk alleles. Segmental glomerulosclerosis did not differ significantly between groups. Presence of two of the following discriminatory histopathologic findings from discovery, that is, <50% obsolescent glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilatation, was specific for the presence of two APOL1 risk alleles in the validation phase. African Americans with arterionephrosclerosis who possess two APOL1 risk variants more often lack obsolescent glomerulosclerosis and have greater degrees of (solidified and disappearing) glomerulosclerosis, thyroidization-type tubular atrophy, and microcystic tubular dilation than patients with fewer than two risk variants. These findings support involvement of multiple cell types in subnephrotic forms of APOL1-associated nephropathy, particularly renal tubule cells with resultant tubulointerstitial disease.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 50 条
  • [1] The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease
    Madhavan, Sethu M.
    O'Toole, John F.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) : 238 - 242
  • [2] The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease
    Sethu M. Madhavan
    John F. O’Toole
    Clinical and Experimental Nephrology, 2014, 18 : 238 - 242
  • [3] APOL1 Kidney Disease Risk Variants: An Evolving Landscape
    Dummer, Patrick D.
    Limou, Sophie
    Rosenberg, Avi Z.
    Heymann, Jurgen
    Nelson, George
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    SEMINARS IN NEPHROLOGY, 2015, 35 (03) : 222 - 236
  • [4] APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
    Parsa, Afshin
    Kao, W. H. Linda
    Xie, Dawei
    Astor, Brad C.
    Li, Man
    Hsu, Chi-yuan
    Feldman, Harold I.
    Parekh, Rulan S.
    Kusek, John W.
    Greene, Tom H.
    Fink, Jeffrey C.
    Anderson, Amanda H.
    Choi, Michael J.
    Wright, Jackson T., Jr.
    Lash, James P.
    Freedman, Barry I.
    Ojo, Akinlolu
    Winkler, Cheryl A.
    Raj, Dominic S.
    Kopp, Jeffrey B.
    He, Jiang
    Jensvold, Nancy G.
    Tao, Kaixiang
    Lipkowitz, Michael S.
    Appel, Lawrence J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23) : 2183 - 2196
  • [5] Balancing the genetic risk of APOL1 kidney disease variants
    Kabore, Nongodo Firmin
    Limou, Sophie
    NEPHROLOGIE & THERAPEUTIQUE, 2019, 15 : S79 - S84
  • [6] The Mechanism of Kidney Disease Due to APOL1 Risk Variants
    Pays, Etienne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (11): : 2502 - 2505
  • [7] APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection
    Purswani, Murli U.
    Patel, Kunjal
    Winkler, Cheryl A.
    Spector, Stephen A.
    Hazra, Rohan
    Seage, George R., III
    Mofenson, Lynne
    Karalius, Brad
    Scott, Gwendolyn B.
    Van Dyke, Russell B.
    Kopp, Jeffrey B.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (01) : 63 - 68
  • [8] APOL1 and kidney disease
    Pollak, Martin R.
    Genovese, Giulio
    Friedman, David J.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (02) : 179 - 182
  • [9] APOL1 Risk Variants Predict Histopathology and Progression to ESRD in HIV-Related Kidney Disease
    Fine, Derek M.
    Wasser, Walter G.
    Estrella, Michelle M.
    Atta, Mohamed G.
    Kuperman, Michael
    Shemer, Revital
    Rajasekaran, Arun
    Tzur, Shay
    Racusen, Lorraine C.
    Skoreckis, Karl
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (02): : 343 - 350
  • [10] The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease
    Estrella, Michelle M.
    Parekh, Rulan S.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 520 - 529